Gene Sequencing – to the bedside

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Gene Sequencing – to the Bedside

Reporter: Larry H Bernstein, MD, FCAP

Gene sequencing leaves the laboratory

Maturing technology speeds medical diagnoses.
Erika Check Hayden  19 February 2013
The steep fall in the cost of sequencing a genome has, for the moment, slowed. Yet researchers attending this year’s Advances in Genome Biology and Technology (AGBT) meeting in Marco Island, Florida, on 20–23 February are not complaining. At a cost as low as US$5,000–10,000 per human genome, sequencing has become cheap and reliable enough that researchers are not waiting for the next sequencing machine to perfect new applications in medicine.
Single-cell genomics is allowing fertility clinics to screen embryos for abnormalities more cheaply.

View original post 29 more words


About luciavazine

This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s